Table 3: Comparison of different indicators in different severity DCAN.

T2DM value value
No-DCAN group ()Early-DCAN group ()Definite-DCAN group ()

Age (yrs)48.00 ± 14.8956.56 ± 10.8257.17 ± 17.071.8340.167
Duration of DM (yrs)7.32 ± 9.359.81 ± 7.569.03 ± 8.570.3830.683
BMI (kg/m2)26.30 ± 4.3225.61 ± 4.2727.70 ± 7.910.9740.382
SBP (mmHg)131.09 ± 15.12133.35 ± 21.52131.23 ± 15.510.1270.881
DBP (mmHg)75.00 ± 8.3381.12 ± 15.4678.77 ± 13.010.8650.425
Waist circumference (cm)92.36 ± 10.6192.79 ± 12.3795.47 ± 14.690.4060.668
Resting Heart rate (bmp)71.00 ± 7.4872.62 ± 8.3678.53 ± 10.400.7070.497
(%)9.05 ± 2.078.50 ± 2.219.28 ± 2.430.9440.300
FPG (mmol/L)7.58 ± 3.158.11 ± 2.988.34 ± 2.751.0740.347
FC-P (ng/mL)1.87 ± 0.611.38 ± 0.901.63 ± 0.941.5100.228
FINS (uIU/mL)12.43 ± 6.6313.46 ± 4.5715.25 ± 15.250.3820.684
Mean hands ESC (μS)79.73 ± 13.177.81 ± 14.167.33 ± 15.374.916
Mean feet ESC (μS)72.32 ± 17.675.91 ± 8.757.77 ± 20.9910.707<0.00

Data were mean ± SD for continuous variables and (%) for categorical variables. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; FC-P, fasting C-peptide; FINS, fasting insulin; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; T2DM, type 2 diabetes mellitus; HC, health controls; DCAN, diabetic cardiovascular autonomic neuropathy; no-DCAN, no diabetic cardiovascular autonomic neuropathy; ESC, electrochemical skin conductance; values and values were for one-way ANOVA across the 3 groups. ; ; ; , compared with the diagnosed DCAN group. . .